Comparative study of atrial peptides ANF (1-98) and ANF (99-126) as diagnostic markers of atrial distension in patients with cardiac disease

References

• deBold A J., Borenstein H B., Veress A T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89–94
   PubMed Web of Science ®Google Scholar
• Flynn T G., deBold M L., deBold A J. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Comm 1983; 117: 89–94
   Web of Science ®Google Scholar
• Kangawa K, Matsuo H. Purification and complete amino acid sequence of alfa-human atrial natriuretic polypeptide. Biochem Biophys Res Commun 1984; 118: 131–9
   PubMed Web of Science ®Google Scholar
• Kangawa K, Fukuda A, Matsuo H. Structural identification of beta- and gamma-human atrial natriuretic polypeptide. Nature 1985; 313: 397–400
   PubMed Web of Science ®Google Scholar
• Needleman P, Adams S, Cole B R., Currie M G., Geller D M., Michener M L., Saper C B., Schwartz D, Standeart D G. Atriopeptines as cardiac hormones. Hypertension 1985; 7: 469–82
   PubMed Web of Science ®Google Scholar
• Thibault G, Garcia R, Gutkowska J, Bilodeau J, Lazure C, Seidah N G., Chretien M, Genest J, Cantin M. The propeptide Asn 1-Tyr 126 is the storage form of rat atrial natriuretic factor. Biochem J 1987; 241: 265–72
   PubMed Web of Science ®Google Scholar
• Itoh H, Nakao K, Sugawara A, Saito Y, Mukoyama M, Morii N, Yamada T, Shiono S, Arai H, Hosoda K, Imura H. Gamma-Atrial natriuretic polypeptide (gammaANP)-derived peptides in human plasma: Cosecretion of Nterminal gammaANP fragment and alfaANP. J Clin Endocrinol Metab 1988; 67: 429–37
   PubMed Web of Science ®Google Scholar
• Bolli P, Muller F B., Under L, Raine A EG, Resink A TJ, Erne P, Kiowski W, Ritz R, Biihler F R. The vasodilatory potency of atrial natriuretic peptide in man. Circulation 1987; 75: 221–8
   PubMed Web of Science ®Google Scholar
• Brands M W., Freeman R H. Aldosterone and renin inhibition by physiological levels of atrial natriuretic factor. Am J Physiol 1988; 254: R1011–16
   PubMedGoogle Scholar
• Itoh H, Nakao K, Yamada T, Morii N, Sugawara A, Shiono S, Saito S, Mukoyama M, Arai H, Katsuura G, Eigyo M, Matsushita A, Imura H. Modulatory role of vasopressin in secretion of atrial natriuretic polypeptide in concious rats. Endocrinology, 120: 2186–8
   PubMed Web of Science ®Google Scholar
• Winthers C J., Sallman A L., Meadows J, Rico D M., Vesely D L. Two new hormones: Prohormone atrial natriuretic peptides 1–30 and31–67 circulate in man. Biochem Biophys Res Commun 1988; 150: 231–6
   PubMed Web of Science ®Google Scholar
• Winters C J., Sallman A L., Baker B J., Meadows J, Rico D M., Vesely D L. The N-terminus and a 4000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Circulation 1989; 80: 438–49
   PubMed Web of Science ®Google Scholar
• Vesely D L., Cornett L E., MacLeod S L., Nash A A., Norris J S. Specific binding sites for prohormone atrial natriuretic peptides 1–30, 31–67 and 99–126. Peptides 1990; 11: 193–7
   PubMed Web of Science ®Google Scholar
• Chen Y M., Whitson P A., Cintron N M. Immuno-reactive prohormone atrial natriuretic peptides 1–30 and 31–67: Existence of a single circulating amino-terminal peptide. Biochem Biophys Res Commun 1990; 166: 794–800
   PubMed Web of Science ®Google Scholar
• Sundsfjord J A., Thibault G, Larochelle P, Cantin M. Identification and plasma concentration of the N terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 1988; 66: 605–10
   PubMed Web of Science ®Google Scholar
• Buckley M G., Sagnella G A., Markandu N D., Singer D RJ, MacGregor G A. Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure. Clinical Science 1989; 77: 573–9
   Web of Science ®Google Scholar
• Edwards B S., Zimmermann R S., Schwab T R., Heublein D M., Burnett J C. Atrial stretch, not pressure, is the principle determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988; 62: 191–5
   PubMed Web of Science ®Google Scholar
• Dietz J R. Release of natriuretic factor from rat heart-lung preparation by atrial distension. Am J Physiol 1984; 247: R1093–6
   PubMed Web of Science ®Google Scholar
• Dietz J R., Nazian S J., Vesely D L. Release of ANF, proANF 1–98, and proANF 31–67 from isolated rat atria by atrial distension. Am J Physiol 1991; 260: H1774–8
   PubMedGoogle Scholar
• Riddervold F, Smiseth O A., Hall C, Groves G, Risoe C. Rate-induced increase in plasma atrial natriuretic factor can occur independently of changes in atrial wall stretch. Am J Physiol 1991; 260: HI953–8
   Google Scholar
• Christensen G, Aksnes G, Ilebekk A, Kiil F. Release of atrial natriuretic factor during selective cardiac alpha- and beta-adrenergic stimulation, intracoronary Ca+ infusion and aortic constriction in pigs. Circ Res 1991; 68: 638–44
   PubMed Web of Science ®Google Scholar
• Tikkanen J, Fyhrquist F, Metsarinne K, Leidenius R. Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy subjects. Lancet 1985; ii: 66–9
   Google Scholar
• Nakaoka H, Imitaka K, Amano M, Fujii J, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic factor in patients with congestive heart failure. N Engl J Med 1985; 313: 892–93
   PubMed Web of Science ®Google Scholar
• Thibault G, Murthy K K., Gutkowska J, Seidah N G., Lazure C, Chretien M, Cantin M. NH2-terminal fragment of rat proatrial natriuretic factor in the circulation: Identification, radioimmunoassay and half-life. Peptides 1988; 9: 47–53
   PubMed Web of Science ®Google Scholar
• The Criteria Committee of the New York Heart Association, Inc. Diseases of the heart and blood vessels; nomenclature and criteria for diagnosis, edn 6. Little, Brown & Co, Boston 1964
   Google Scholar
• Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. J Clin Endocrinol Metab 1986; 63: 819–22
   PubMed Web of Science ®Google Scholar
• Cockroft D W., Gault M H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41
   PubMed Web of Science ®Google Scholar
• Cardiac catheterization and angiography, edn 3, W Grossman. Lea & Febiger, Philadelphia 1986
   Google Scholar
• Bois Du, Bois Du. Arch Intern Med 1916; 17: 863
   Google Scholar
• Richards A M., Cleland J GF, Tonolo G, McLntyre G D., Leckie B J., Dargie H J., Ball S G., Robertson J IS. Plasma alpha natriuretic peptide in cardiac impairment. Br Med J 1986; 293: 409–12
   PubMed Web of Science ®Google Scholar
• Bates E R., Shenker Y, Grekin R J. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation 1986; 73: 1155–61
   PubMed Web of Science ®Google Scholar
• Sato F, Kamoi K, Wakiya Y, Ozawa T, Arai O, Ishibashi M, Yamaji T. Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man. J Clin Endocrinol Metab 1986; 63: 823–7
   PubMed Web of Science ®Google Scholar
• Takayanagi R, Imada T, Inagami T. Synthesis and presence of atrial natriuretic factor in rat ventricle. Biochem Biophys Res Comm 1987; 142: 483–8
   PubMed Web of Science ®Google Scholar
• Thibault G, Nemer M, Drouin J, Lavigne J P., Ding J, Charbonneau C, Garcia R, Genest J, Jasmin G, Sole M, Cantin M. Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopathic hamsters with heart failure. Circ Res 1989; 65: 71–82
   PubMed Web of Science ®Google Scholar
• Yasue H, Obata K, Okumura K, Kurose M, Ogawa H, Matsuyama K, Jougasaki M, Saito Y, Kakao K, Imura H. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest 1989; 83: 46–51
   PubMed Web of Science ®Google Scholar
• Ruskoaho H, Kinnunen P, Mantymaa P, Taskinen T, Vuolteenaho O. Ventricular stretch releases atrial natriuretic peptide from hypertrophied rat myocardium. Circulation 1990; 82(Suppl III)86
   Google Scholar
• Hintze T H., McIntyre J J., Patel M B., Shapiro J T., DeLeonardis M, Zeballos G A., Loud A V. Atrial wall function and plasma atriopeptin during volume expansion in conscious dogs. Am J Physiol 1989; 256: H713–9
   PubMed Web of Science ®Google Scholar
• Haass M, Dietz R, Fisher T A., Lang R E., Kubler W. Role of right and left atrial dimensions for release of atrial natriuretic peptide in left-sided valvular heart disease and idiopathic dilated cardiomyopathy. Am J Cardiol 1988; 62: 764–70
   PubMed Web of Science ®Google Scholar
• Moe G W., Howard R J., Angus C, de Bold A J., Armstrong P W. Pathophysiological role of atrial size and pressure in themodulation of plasma natriuretic factor during evolving experimental heart failure (abstr). Circulation 1976; 76(suppl IV)IV-135
   Google Scholar
• Keller N, Møgelvang J, Saunamaki K, Fritz-Hansen P, Sykulski R, Henriksen O. Determinants of atrial natriuretic factor levels in coronary heart disease: significance of central pressures, heart chamber volumes and left ventricular mass. J Intern Med 1989; 226: 195–200
   PubMed Web of Science ®Google Scholar